100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human NFkB2 (Nuclear Factor Kappa B2) ELISA (Small Sample Volume) (AEKE08389)

SKU AEKE08389
Reactivity Human
Detection Method Sandwich
Sensitivity 0.13 ng/mL
Standard 20 ng/mL
Range 0.32-20 ng/mL
€649 - €5,841

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Human NFkB2 ELISA Kit (Small Sample Volume)

Human NFkB2 ELISA kits are used to detect Nuclear Factor Kappa B2 (NFkB2) in tissue homogenates and other biological samples. NFkB2 encodes the p100 precursor and its processed p52 form, members of the NF-kappa-B family of Rel-domain transcription factors that regulate genes involved in inflammation, immunity, differentiation, cell growth and survival. The p100 form is bound to RelB and retained in the cytoplasm, and in the non-canonical pathway activation of the kinase NIK and IKK-alpha triggers its partial proteolysis to p52, allowing RelB-p52 dimers to enter the nucleus and activate transcription, whereas p52 homodimers tend to repress it. This pathway is important for B-cell maturation and the formation of lymphoid organs. Chromosomal rearrangements and truncations of NFKB2 have been reported in lymphoid malignancies, and mutations are associated with an immunodeficiency disorder.

system_update_altDatasheetsystem_update_altMSDS
View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose